English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[2004]
News
[3333]
Articles
[144]
Editorials
[3]
Conferences
[125]
e
learning
[18]
Team discovers how to target ‘undruggable’ protein that fuels aggressive leukaemia
ASH 2025: Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or...
ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL
ASH 2025: Measurable residual disease shows strong potential as an early indicator of survival in acute myeloid...
ASH 2025: Continuous and fixed-duration treatments result in similar outcomes for CLL
ASH 2025: Chemo and radiation are comparable as pre-transplant conditioning for B-acute lymphoblastic leukaemia...
A routine blood test could help predict who benefits most from CAR T-cell therapy
ASH 2025: Milder chemo works for rare, aggressive lymphoma
Study finds childhood leukaemia aggressiveness depends on timing of genetic mutation
Prognostic tool could help clinicians identify high-risk cancer patients
<
1
2
3
4
5
…
334
>
More from
e
cancer